Sunday, September 25, 2011

Eculizumab Gains FDA Approval - Drug Discovery & Development

Viking Refrigerators


Eculizumab Gains FDA Approval

Drug Discovery & Development


The US Food and Drug Administration (FDA) granted accelerated approval for eculizumab (Soliris, Alexion Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab is a monoclonal antibody that ...


Eculizumab receives accelerated approval for pediatric, adult hemolytic uremic ...

HemOncToda! y


FDA Approves Soliris for Rare Pediatric Blood Disorder

MarketWatch (press release)


FDA Approves Alexion's Soliris For Treatment Of AHUS - Update

RTT News



 »

No comments:

Post a Comment